Where does Rosetta Genomics Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rosetta Genomics Ltd. ranks #11,061 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rosetta Genomics Ltd. hold?

Rosetta Genomics Ltd. holds 28 US utility patents granted between 2015 and 2019, spanning 6 technology areas.

What is Rosetta Genomics Ltd.'s Innovation Score?

Rosetta Genomics Ltd. has an Innovation Score of 26.2 out of 100 (20th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Rosetta Genomics Ltd.'s patent grant rate increasing or decreasing?

Rosetta Genomics Ltd.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Rosetta Genomics Ltd.'s patents?

Rosetta Genomics Ltd.'s patents average 9.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rosetta Genomics Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Rosetta Genomics Ltd.

Q: What technology areas does Rosetta Genomics Ltd. focus on?

Rosetta Genomics Ltd.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 23 patents, ranking #200 of 2,502 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 28 granted patents across 6 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rosetta ranks #11,061 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 6 technology areas.

#11,061
of 49,997 US assignees by volume: 20th percentile
by Innovation Score (26.2/100): 9.9
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11061 · Foreign Corporation #11,061 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #11,061/49,997
PHOTO-FINISH Rivada Research
CPC-NARROW C12Q · 6 areas
INNOV-THIN 26.2/100
CLAIMS-PAR 9.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rivada Research, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rosetta’s 26.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (44%) Velocity 0.0 pts (0%) Breadth 8.7 pts (33%) Claim depth 5.9 pts (23%)

Qualcomm Incorporated · highest

85
Pretium Packaging L… · near

26
Bloomy Lotus · near

26
Capcom · near

26
Regenerative… · near

26
Rosetta Genomics · this assignee

26
3D Lighting… · lowest

7

What this shows Rosetta's Innovation Score is 26.2/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rosetta?

Each dot is one of Rosetta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rosetta’s own 9.9 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Rosetta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rosetta's grants concentrate

Rosetta Genomics Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 82.1% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (10 grants) versus a trough of 1 in 2019. By volume, Rosetta sits between Rivada Research, LLC and Shakespeare Company, LLC.

Rivada Research

28
Rock River Arms

28
Rock-tenn Shared…

28
Roka Sports

28
Sango

28
Sapproro Medical…

28
Schroeder Industr…

28
Shakespeare

28
Rosetta Genomics ◀

28

What this shows Rosetta holds 28 patents at rank #11,059, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rosetta

By rank, the assignees closest to #11,059 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Rosetta's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Rosetta, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Rosetta ranks #200 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (26 here).

Capcom Co., Ltd. 26 Bloomy Lotus Limited 26 Regenerative Research Foundation 26 Pretium Packaging, L.L.C. 26

Rosetta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 20th percentile higher than 20% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rosetta Genomics Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	28.6%
2016	5	17.9%
2017	10	35.7%
2018	4	14.3%
2019	1	3.6%

Which technologies does Rosetta Genomics Ltd. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 23

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

Y02A - Technologies FOR Adaptation TO Climate Change 5

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rosetta Genomics Ltd.'s patent record in context - here's where to go next.

Rosetta Genomics Ltd.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 82.1% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #11,061 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rosetta Genomics Ltd. against Rivada Research, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.